Real-time enrollment status for this hiv-1-infection clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 3:14 PM UTC
| NCT Number | NCT07683000 |
| Recruiting Status | Recruiting |
| Condition | HIV-1-infection |
| Phase | PHASE3 |
| Target Enrollment | 590 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | July 30, 2026 (Jul 30, 2026) |
As of August 30, 2026: Clinical trial NCT07683000 is currently recruiting participants. This phase3 study for hiv-1-infection is actively seeking new participants at 2 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07683000 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07683000 was last updated Jul 30, 2026 (July 30, 2026). HelloStudys verifies this status automatically.